top of page
Home: Welcome

Spring 2025
Search


Racial Inequities in Severe Maternal Health Outcomes
Authored by: Surabhi Shastry Art by: Stefanie Chen Racial inequities in severe maternal morbidity (SMM) and pregnancy-related mortality in the United States are a critical, persistent public health crisis. National data consistently show that Black birthing people face pregnancy-related deaths and SMM at rates three times higher than White birthing people, and these disparities have not shown substantial improvement over time [1]. State-level analyses reveal that the magnitud
Surabhi Shastry
Jan 64 min read


Weaponizing Section 1498 Against GLP-1 Manufacturers
Authored by: Sriram Chakravadhanula Art by: Carol Zhang In March 2024, the U.S. Food and Drug Administration (FDA) approved GLP-1 medication for heart disease, in addition to its application for diabetes, leading to a massive increase in GLP-1 users. The United States became the largest market for Ozempic and Wegovy supplier, Novo Nordisk, with over 71% of the Company’s drug sales come from the United States[1]. As Senator Warren revealed, Ozempic is priced at $936 in the US
Sriram Chakravadhanula
Jan 64 min read
“Indian Pot Belly”: Tracing a Silent Epidemic
Authored by: Srijita Kommaraju On a summer vacation to my home country, India, I was astonished by how casually my relatives manage their health. Heaping plates full of white rice, rotis, and curries were eaten thoroughly, followed by metformin tablets and insulin injections. This was so normalized that no one thought to question it. And for a while, I didn’t either. But then it hit me. Everywhere I looked, my uncles, grandparents, and even strangers passing down the street
Srijita Kommaraju
Jan 63 min read
CONTACT
bottom of page
